Canada Life’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.3M Buy
205,284
+588
+0.3% +$147K 0.08% 213
2025
Q4
$49.4M Buy
204,696
+38,289
+23% +$9.79M 0.09% 197
2025
Q3
$45.1M Sell
166,407
-218
-0.1% -$59.5K 0.06% 264
2025
Q2
$43M Buy
166,625
+4,595
+3% +$1.1M 0.07% 254
2025
Q1
$36.3M Buy
162,030
+1,115
+0.7% +$260K 0.06% 273
2024
Q4
$36.8M Buy
160,915
+15,389
+11% +$3.71M 0.06% 266
2024
Q3
$35.6M Buy
145,526
+22,145
+18% +$4.95M 0.06% 288
2024
Q2
$23.7M Buy
123,381
+5,102
+4% +$1.04M 0.04% 359
2024
Q1
$23.4M Sell
118,279
-167
-0.1% -$30.6K 0.05% 355
2023
Q4
$20.3M Buy
118,446
+6,918
+6% +$1.06M 0.04% 367
2023
Q3
$16.5M Buy
111,528
+514
+0.5% +$92.9K 0.04% 410
2023
Q2
$24.4M Sell
111,014
-4,913
-4% -$1.09M 0.06% 317
2023
Q1
$25.4M Sell
115,927
-86
-0.1% -$18.7K 0.06% 302
2022
Q4
$24.3M Sell
116,013
-811
-0.7% -$178K 0.06% 300
2022
Q3
$25.5M Sell
116,824
-4,652
-4% -$1.06M 0.07% 275
2022
Q2
$25.5M Buy
121,476
+1,631
+1% +$347K 0.07% 289
2022
Q1
$30.6M Sell
119,845
-911
-0.8% -$220K 0.06% 302
2021
Q4
$31.4M Buy
120,756
+3,159
+3% +$820K 0.06% 306
2021
Q3
$31.2M Sell
117,597
-1,673
-1% -$457K 0.07% 287
2021
Q2
$29.4M Sell
119,270
-3,686
-3% -$775K 0.07% 313
2021
Q1
$23.7M Buy
122,956
+5,302
+5% +$1.06M 0.06% 347
2020
Q4
$25M Sell
117,654
-1,337
-1% -$267K 0.05% 375
2020
Q3
$20.4M Buy
118,991
+2,639
+2% +$487K 0.04% 378
2020
Q2
$22.2M Sell
116,352
-543
-0.5% -$88.8K 0.05% 336
2020
Q1
$17.3M Buy
116,895
+3,617
+3% +$576K 0.05% 335
2019
Q4
$17.4M Sell
113,278
-41,294
-27% -$5.95M 0.04% 413
2019
Q3
$20.9M Buy
154,572
+2,893
+2% +$379K 0.05% 372
2019
Q2
$18.5M Buy
151,679
+45,891
+43% +$5.08M 0.04% 396
2019
Q1
$11M Buy
105,788
+19,852
+23% +$2.05M 0.03% 473
2018
Q4
$9.31M Sell
85,936
-2,002
-2% -$214K 0.03% 484
2018
Q3
$10.2M Sell
87,938
-10,094
-10% -$1.11M 0.02% 511
2018
Q2
$10.2M Buy
98,032
+448
+0.5% +$45.3K 0.02% 524
2018
Q1
$9.62M Sell
97,584
-3,079
-3% -$291K 0.02% 545
2017
Q4
$8.52M Sell
100,663
-22,942
-19% -$1.9M 0.02% 583
2017
Q3
$9.39M Sell
123,605
-52,168
-30% -$3.99M 0.02% 537
2017
Q2
$13.7M Sell
175,773
-144
-0.1% -$10.3K 0.04% 425
2017
Q1
$12.6M Buy
175,917
+4,882
+3% +$337K 0.03% 437
2016
Q4
$10.6M Sell
171,035
-8,127
-5% -$498K 0.03% 464
2016
Q3
$11.6M Buy
179,162
+33,733
+23% +$2.25M 0.03% 449
2016
Q2
$9.19M Buy
145,429
+108,084
+289% +$6.37M 0.03% 496
2016
Q1
$2.16M Buy
37,345
+4,356
+13% +$247K 0.01% 716
2015
Q4
$1.77M Buy
32,989
+6,708
+26% +$378K 0.01% 748
2015
Q3
$1.34M Buy
26,281
+4,589
+21% +$247K 0.01% 778
2015
Q2
$1.22M Sell
21,692
-2,496
-10% -$158K ﹤0.01% 888
2015
Q1
$1.73M Sell
24,188
-614
-2% -$39.9K 0.01% 825
2014
Q4
$1.39M Sell
24,802
-1,600
-6% -$83.5K ﹤0.01% 843
2014
Q3
$1.3M Buy
26,402
+4,041
+18% +$206K ﹤0.01% 851
2014
Q2
$1.13M Hold
22,361
﹤0.01% 849
2014
Q1
$997K Sell
22,361
-20,596
-48% -$925K ﹤0.01% 854
2013
Q4
$2.03M Sell
42,957
-50,375
-54% -$2.55M 0.01% 772
2013
Q3
$4.93M Buy
93,332
+21,732
+30% +$1.05M 0.02% 558
2013
Q2
$3.23M Buy
+71,600
New +$3.4M 0.02% 357

Other funds holding RMD

Canada Life's RMD Position: Q1 2026 in Review

Canada Life increased its ResMed (RMD) stake by 0.29% in Q1 2026, buying an estimated $147K and bringing the position to 205,284 shares worth $46.3M. The position accounts for 0.08% of the portfolio, ranked #213.

Canada Life first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $49.4M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Canada Life held 205,284 shares of ResMed worth $46.3M as of Q1 2026.
  • Canada Life bought 588 ResMed shares in Q1 2026, an estimated $147K.
  • ResMed made up 0.08% of Canada Life's portfolio in Q1 2026, its #213 holding.
  • Canada Life first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's ResMed position peaked at $49.4M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.